Global Transthyretin Amyloidosis Treatment Industry: Advancing...

bir ses eklendi Other

2026-11-05 11:34:35 -

Global Transthyretin Amyloidosis Treatment Industry: Advancing Therapeutic Innovation and Patient Care

The global healthcare and pharmaceutical industries are placing increasing emphasis on transthyretin amyloidosis (ATTR) as advances in disease understanding and treatment development create new opportunities for patient care. ATTR is a rare condition associated with the accumulation of misfolded transthyretin proteins in tissues, potentially affecting the heart, nerves, and other organs. Its...

0 Yorumlar 0 hisse senetleri 37 Views 0 önizleme